Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care “Menopausal disorders and other disorders in the perimenopausal period”
Order of the Ministry of Health of Ukraine dated June 17, 2022 No. 1039
DOI:
https://doi.org/10.18370/2309-4117.2023.67.8-29Keywords:
clinical protocol, Ministry of Health of Ukraine, menopausal disorders, STRAW 10 criteria, menopausal hormone therapyAbstract
This protocol was developed on the basis of the clinical guideline “Menopausal disorders and other disorders in the perimenopausal period”, which is based on the principles of evidence-based medicine and takes into account the clinical guideline Recommendations on Women’s Midlife Health and Menopause Hormone Therapy, developed in 2016 by specialists of the International Menopause Society (IMS), and corresponds to the specifics of providing medical care in our country.
Also, other international guidelines on menopause issues were used in the development of this protocol, such as: “Menopause: diagnosis and management” National Institute for Health and Care Excellence (NICE) guideline, 2019; сlinical guidance “Managing menopausal symptoms” Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), 2020; “The genitourinary syndrome of menopause” North American Menopause Society, (NAMS), 2020; British Menopause Society (BMS) & Women’s Health Concern (WHC) recommendations on hormone replacement therapy in menopausal women, 2020.
The goal of the protocol: to ensure the organization of medical care, to establish uniform requirements for the diagnosis and treatment of patients with menopausal symptoms, to recommend the use of STRAW+10 (2011) criteria for menopause to all health care professionals.
The protocol describes the organization of medical care for patients with menopausal disorders at all levels – from primary to tertiary care. Detailed information on diagnosis and treatment of this category of patients is presented. Special attention is paid to menopausal hormone therapy, taking into account its possible risks.
The protocol is intended for general practitioners – family doctors, obstetrician-gynecologists, gynecological oncologists, oncologists, oncological surgeons, cardiologists, endocrinologists, orthopedic traumatologists and other medical professionals who provide medical assistance to women with menopausal disorders.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 -
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.